NetworkNewsBreaks – Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) Subsidiary Enters Manufacturing and Supply Agreement in California

Vancouver-based biopharmaceutical company Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) this morning announced that its wholly-owned California subsidiary, Pivot Naturals, LLC, has signed a definitive manufacturing and supply agreement with Stoney LLC, a leading brand of cannabis products in the state of California. Per the terms of the agreement, Stoney has agreed to purchase Pivot’s suite of Ready-To-Infuse-Cannabis (“RTIC”) powderized products, including formulated capsules for targeted effects, bulk powder for baking additives, single serve stick packs and pet food supplements. Order quantities will be determined in rolling 30-day periods commencing in 2018. “I am thrilled to execute our first Manufacturing and Supply Agreement in California,” Patrick J. Rolfes, president of Pivot Naturals, stated in the news release. “This positions our patented RTIC powderization technology as an industry changing solution. This is a critical milestone that further validates Pivot as a leading supplier of premium, science-based cannabis products.”

To view the full press release, visit http://nnw.fm/2UnB8

About Pivot Pharmaceuticals Inc.

Pivot Pharmaceuticals Inc. is a biopharmaceutical company engaged in the development and commercialization of therapeutic pharmaceuticals and nutraceuticals using innovative drug delivery platform technologies. Pivot’s wholly-owned medical cannabis products division, Pivot Green StreamHealth Solutions Inc. (“PGS”), conducts research, development and commercialization of cannabinoid-based nutraceuticals and pharmaceuticals. PGS has acquired worldwide rights to “RTIC” Ready-To-Infuse Cannabis powder to oil technology, BiPhasix Transdermal Drug Delivery platform technology (topical), Solmic Solubilisation technology (oral) and Thrudermic Transdermal Nanotechnology (transdermal) for the delivery and commercialization of cannabinoid, cannabidiol, and tetrahydrocannabinol-based products. PGS’ initial product development candidates will include topical treatments for women’s sexual dysfunction (PGS-N005), as well as psoriasis (PGS-N007), and an oral product (PGS-N001) for cancer supportive care. For more information, visit the company’s website at www.PivotPharma.com

More from NetworkNewsBreaks

NetworkNewsBreaks – EVIO, Inc. (EVIO) Posts Fiscal Q2 2018 Financial Results NetworkNewsBreaks – Marijuana Company of America, Inc. (MCOA) JV Completes Setup of 10,000 sq. ft. Greenhouse Space NetworkNewsBreaks – FANDOM SPORTS Media Corp. (CSE: FDM) (OTC: FDMSF) (FRA: TQ42) Announces Digital User Acquisition Initiatives

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

More News From Banking Reporter

Brazilian leader at odds with Davos focus on environment

Jan 22, 2019

DAVOS, Switzerland — Brazilian President Jair Bolsonaro pledged to work "in harmony with the world" to cut carbon emissions, aiming to quell international concerns that his country, the main custodian of the oxygen-rich Amazon, could put economic interests over environmental ones. The environment dominated talks at the World Economic Forum on Tuesday, and the nationalist leader struck a conciliatory tone in a keynote speech — a far cry from the combative one he had taken on the campaign trail when he once threatened to join the United States and pull Brazil out of the Paris climate accord, which set a...

The Latest: Merck to ship 120,000 more Ebola vaccine doses

Jan 22, 2019

DAVOS, Switzerland — The Latest on the World Economic Forum in Davos, Switzerland (all times local): 6:30 p.m. Drugmaker Merck says it will ship another approximately 120,000 doses of an experimental Ebola vaccine to Congo by the end of next month amid the second deadliest outbreak in history. Associate Vice President Lydia Ogden told the World Economic Forum that the company is committed to having a ready stockpile of 300,000 doses and already has shipped 100,000 to the World Health Organization. Health officials have called the experimental vaccine highly effective against the virus. Congo's health ministry says more than 63,000...

World shares retreat on fears of global, Chinese slowdown

Jan 22, 2019

SINGAPORE — World markets fell Tuesday after the International Monetary Fund trimmed its global outlook for 2019 and 2020 and China said its economy grew at the slowest pace in nearly 30 years. KEEPING SCORE: Germany's DAX gave up 0.5 percent to 11,076 and France's CAC 40 was down 0.7 percent at 4,834. Britain's FTSE 100 was 0.5 percent lower at 6,934. Wall Street, reopening after Martin Luther King Jr. Day, was set for early losses. Futures for the broad S&P 500 index declined 0.7 percent and Dow futures dropped 0.6 percent. THE DAY IN ASIA: Japan's Nikkei 225 index...

Investor sentiment for Germany ticks up, but still depressed

Jan 22, 2019

FRANKFURT, Germany — A survey of financial experts suggests the outlook for Germany, Europe's largest economy, brightened slightly during January because the worst risks were already reflected in earlier months' readings. The ZEW institute's indicator rose 2.5 points over December's reading to minus 15.0 points. That is still far below the long-term average of plus 22.4 points. ZEW President Achim Wambach said Tuesday earlier surveys were down sharply as respondents anticipated risks to German growth such as a disorderly departure from the European Union by Britain or weaker growth in major trade partner China. He said: "It is remarkable that...

Asian shares decline on concerns over global, China slowdown

Jan 22, 2019

SINGAPORE — Asian markets were mostly lower on Tuesday after the International Monetary Fund trimmed its global outlook for 2019 and 2020. The downgrade came after China said its economy grew at the slowest pace in 30 years in the last quarter of 2018. Wall Street was closed for a holiday on Monday. KEEPING SCORE: Japan's Nikkei 225 index shed 0.7 percent to 20,573.28 and the Kospi in South Korea sank 0.7 percent to 2,110.62. Hong Kong's Hang Seng lost 1.0 percent to 26,921.49. The Shanghai Composite index fell 0.7 percent to 2,591.37. Australia's S&P ASX 200 slipped 0.6 percent...

About Us

Banking Reporter is the largest-circulated online business news in the United States, bringing a whole new genre of business journalism more up close and more incisive.

Contact us: sales[at]bankingreporter.com

Subscribe Now!